Detail page

Knowledge Web

Person

Rosemarie Marchan

Toxikologin

Name	Rosemarie Marchan
Place	Deutschland USA
Gender	weiblich
Academic degree	Dr.
Profession	Toxikologin (characteristic profession)
Related	Technische Universität Dortmund. Leibniz-Institut für Arbeitsforschung (2008-) (Wissenschaftliche Mitarbeiterin, Leiterin der Nachwuchsgruppe Zelluläre Toxikologie)
Further information	Studium der Umweltwissenschaften und der Biologie, Promotion 2007 in den USA
Source	Homepage: http://www.ifado.de/toxikologie/mitarbeiter/rosemarie-marchan/ (23.11.2017)
Record type	Person
GND-Identifier	1145185959
Record ID	1145185959
Involved in show all Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations Adverse outcome pathways: opportunities, limitations and open questions Adverse outcome pathways : opportunities, limitations and open questions Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Rosemarie Marchan

Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth

Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets

The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Adverse outcome pathways: opportunities, limitations and open questions

Adverse outcome pathways : opportunities, limitations and open questions

Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing